Takahiro Ishii

7PUBLICATIONS
35CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2026
An RNA-Focused DNA-Encoded Library Platform for Discovering Ligands of Pathogenic r(G4C2)exp RNA.

|Sep 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their Derivatives.

Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|May 21, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.

Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda

|Oct 20, 2023
Development of anti-HBV agents targeting HBV capsid proteins.

Takuya Kobayakawa, Masayuki Amano, Miyuki Nakayama

|Sep 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.

Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa

Pageof 2

Frequent Collaborators

6 joint publications

Kohei Tsuji

6 joint publications

Hirokazu Tamamura

3 joint publications

Nobuyo Higashi-Kuwata

3 joint publications

Haydar Bulut